# EmboCube Gelatin Embolization to Control Bleeding or Hemorrhaging

> **NCT05307783** · — · COMPLETED · sponsor: **Merit Medical Systems, Inc.** · enrollment: 101 (actual)

## Conditions studied

- Hemorrhage
- Bleeding Hemorrhage

## Interventions

- **DEVICE:** EmboCube Embolization Gelatin

## Key facts

- **NCT ID:** NCT05307783
- **Lead sponsor:** Merit Medical Systems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-30
- **Primary completion:** 2024-03-15
- **Final completion:** 2024-04-10
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05307783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05307783, "EmboCube Gelatin Embolization to Control Bleeding or Hemorrhaging". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05307783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*